Literature DB >> 20388660

Low CD4+ T-cell levels and B-cell apoptosis in vertically HIV-exposed noninfected children and adolescents.

Maristela Miyamoto1, Silvana D Pessoa, Erika Ono, Daisy M Machado, Reinaldo Salomão, Regina C de M Succi, Savita Pahwa, Maria Isabel de Moraes-Pinto.   

Abstract

Lymphocyte subsets, activation markers and apoptosis were assessed in 20 HIV-exposed noninfected (ENI) children born to HIV-infected women who were or not exposed to antiretroviral (ARV) drugs during pregnancy and early infancy. ENI children and adolescents were aged 6-18 years and they were compared to 25 age-matched healthy non-HIV-exposed children and adolescents (Control). ENI individuals presented lower CD4(+) T cells/mm(3) than Control group (control: 1120.3 vs. ENI: 876.3; t-test, p = 0.030). ENI individuals had higher B-cell apoptosis than Control group (Control: 36.6%, ARV exposed: 82.3%, ARV nonexposed: 68.5%; Kruskal-Wallis, p < 0.05), but no statistical difference was noticed between those exposed and not exposed to ARV. Immune activation in CD4(+) T, CD8(+) T and in B cells was comparable in ENI and in Control children and adolescents. Subtle long-term immune alterations might persist among ENI individuals, but the clinical consequences if any are unknown, and these children require continued monitoring.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20388660      PMCID: PMC3107461          DOI: 10.1093/tropej/fmq024

Source DB:  PubMed          Journal:  J Trop Pediatr        ISSN: 0142-6338            Impact factor:   1.165


  27 in total

Review 1.  HIV protease inhibitors impact on apoptosis.

Authors:  Stacey A Rizza; Andrew D Badley
Journal:  Med Chem       Date:  2008-01       Impact factor: 2.745

2.  Severe infections in HIV-exposed uninfected infants: clinical evidence of immunodeficiency.

Authors:  A L Slogrove; M F Cotton; M M Esser
Journal:  J Trop Pediatr       Date:  2009-07-14       Impact factor: 1.165

3.  Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues.

Authors:  S Blanche; M Tardieu; P Rustin; A Slama; B Barret; G Firtion; N Ciraru-Vigneron; C Lacroix; C Rouzioux; L Mandelbrot; I Desguerre; A Rötig; M J Mayaux; J F Delfraissy
Journal:  Lancet       Date:  1999-09-25       Impact factor: 79.321

4.  Apoptosis and the CD95 system in HIV disease: impact of highly active anti-retroviral therapy (HAART).

Authors:  M L Gougeon; H Lecoeur; Y Sasaki
Journal:  Immunol Lett       Date:  1999-03       Impact factor: 3.685

5.  Function and phenotype of immature CD4+ lymphocytes in healthy infants and early lymphocyte activation in uninfected infants of human immunodeficiency virus-infected mothers.

Authors:  K C Rich; J N Siegel; C Jennings; R J Rydman; A L Landay
Journal:  Clin Diagn Lab Immunol       Date:  1997-05

6.  Apoptosis as a mechanism of natural resistance to HIV-1 infection in an exposed but uninfected population.

Authors:  P A Velilla; A Hoyos; M Rojas; P J Patiño; L A Vélez; M T Rugeles
Journal:  J Clin Virol       Date:  2005-04       Impact factor: 3.168

7.  Analysis of HIV-1- and CMV-specific memory CD4 T-cell responses during primary and chronic infection.

Authors:  Alexandre Harari; G Paolo Rizzardi; Kim Ellefsen; Donatella Ciuffreda; Patrick Champagne; Pierre-Alexandre Bart; Daniel Kaufmann; Amalio Telenti; Roland Sahli; Giuseppe Tambussi; Laurent Kaiser; Adriano Lazzarin; Luc Perrin; Giuseppe Pantaleo
Journal:  Blood       Date:  2002-08-15       Impact factor: 22.113

Review 8.  Mechanisms of zidovudine-induced mitochondrial toxicity and myopathy.

Authors:  Erin R Scruggs; Amie J Dirks Naylor
Journal:  Pharmacology       Date:  2008-05-27       Impact factor: 2.547

9.  Apoptotic cell death and cytokine dysregulation in human immunodeficiency virus infection: pivotal factors in disease progression.

Authors:  M Clerici; A Sarin; P A Henkart; G M Shearer
Journal:  Cell Death Differ       Date:  1997-12       Impact factor: 15.828

10.  Gamma interferon production in response to Mycobacterium bovis BCG and Mycobacterium tuberculosis antigens in infants born to human immunodeficiency virus-infected mothers.

Authors:  Annelies Van Rie; Shabir A Madhi; Jayvant R Heera; Stephen Meddows-Taylor; Aaron M Wendelboe; Fiona Anthony; Avy Violari; Caroline T Tiemessen
Journal:  Clin Vaccine Immunol       Date:  2006-02
View more
  22 in total

1.  Outcomes of a National Institute of Allergy and Infectious Diseases Workshop on understanding HIV-exposed but seronegative individuals.

Authors:  Janet M Young; Jim A Turpin; Runa Musib; Opendra K Sharma
Journal:  AIDS Res Hum Retroviruses       Date:  2011-01-15       Impact factor: 2.205

2.  Factors Associated with Lower Respiratory Tract Infections in HIV-Exposed Uninfected Infants.

Authors:  Adriana Weinberg; Marisa M Mussi-Pinhata; Qilu Yu; Rachel A Cohen; Volia C Almeida; Fabiana R Amaral; Laura Freimanis; Donald Robert Harris; Christiana Smith; George Siberry
Journal:  AIDS Res Hum Retroviruses       Date:  2018-04-23       Impact factor: 2.205

Review 3.  The Immune System of HIV-Exposed Uninfected Infants.

Authors:  Bahaa Abu-Raya; Tobias R Kollmann; Arnaud Marchant; Duncan M MacGillivray
Journal:  Front Immunol       Date:  2016-09-28       Impact factor: 7.561

4.  In-utero exposure to maternal HIV infection alters T-cell immune responses to vaccination in HIV-uninfected infants.

Authors:  Elvis B Kidzeru; Anneke C Hesseling; Jo-Ann S Passmore; Landon Myer; Hoyam Gamieldien; Christophe Toukam Tchakoute; Clive M Gray; Donald L Sodora; Heather B Jaspan
Journal:  AIDS       Date:  2014-06-19       Impact factor: 4.177

5.  Impaired haemophilus influenzae type b transplacental antibody transmission and declining antibody avidity through the first year of life represent potential vulnerabilities for HIV-exposed but -uninfected infants.

Authors:  James T Gaensbauer; Jeremy T Rakhola; Carolyne Onyango-Makumbi; Michael Mubiru; Jamie E Westcott; Nancy F Krebs; Edwin J Asturias; Mary Glenn Fowler; Elizabeth McFarland; Edward N Janoff
Journal:  Clin Vaccine Immunol       Date:  2014-10-08

Review 6.  HIV-exposed uninfected children: a growing population with a vulnerable immune system?

Authors:  L Afran; M Garcia Knight; E Nduati; B C Urban; R S Heyderman; S L Rowland-Jones
Journal:  Clin Exp Immunol       Date:  2014-04       Impact factor: 4.330

7.  The evolution of haematological and biochemical indices in HIV patients during a six-month treatment period.

Authors:  J Mgogwe; H Semvua; R Msangi; C Mataro; D Kajeguka; J Chilongola
Journal:  Afr Health Sci       Date:  2012-03       Impact factor: 0.927

Review 8.  Immunology of pediatric HIV infection.

Authors:  Nicole H Tobin; Grace M Aldrovandi
Journal:  Immunol Rev       Date:  2013-07       Impact factor: 12.988

9.  Effect of multivitamin supplementation on measles vaccine response among HIV-exposed uninfected Tanzanian infants.

Authors:  Christopher R Sudfeld; Christopher Duggan; Alex Histed; Karim P Manji; Simin N Meydani; Said Aboud; Molin Wang; Edward L Giovannucci; Wafaie W Fawzi
Journal:  Clin Vaccine Immunol       Date:  2013-05-29

10.  Antibody responses to vaccination among South African HIV-exposed and unexposed uninfected infants during the first 2 years of life.

Authors:  Brian A Reikie; Shalena Naidoo; Candice E Ruck; Amy L Slogrove; Corena de Beer; Heleen la Grange; Rozanne C M Adams; Kevin Ho; Kinga Smolen; David P Speert; Mark F Cotton; Wolfgang Preiser; Monika Esser; Tobias R Kollmann
Journal:  Clin Vaccine Immunol       Date:  2012-10-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.